Security key
00847X104
AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO)
CUSIP: 00847X104
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, Par Value $0.001 per share
- Shares outstanding
- 59,431,072
- Total 13F shares
- 61,265,073
- Share change
- -4,066,127
- Total reported value
- $1,667,804,671
- Put/Call ratio
- 32%
- Price per share
- $27.22
- Number of holders
- 237
- Value change
- -$303,118,531
- Number of buys
- 135
- Number of sells
- 113
Report period
Q4 2025
Institutions
237
Top holders
10
AGIO full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
AGIOS PHARMACEUTICALS, INC. SEC filings
AGIOS PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00847X104
Recent filing periods:
Top shareholders of AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Farallon Capital Partners, L.P. |
13D/G
|
Dapice Joshua J. |
8.8%
|
5,159,505
|
$146,117,182 | -$14,583,696 | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.8%
from 13D/G
|
4,545,738
|
$182,465,924 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
13D/G
|
Company · STATE STREET CORPORATION |
5.3%
from 13D/G
|
2,262,712
|
$90,825,260 | — | 30 Sep 2025 | |
| Paradigm Biocapital Advisors LP |
13D/G
13F
|
Company |
4.9%
|
2,873,555
|
$115,344,498 | -$6,198,499 | 30 Sep 2025 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
9.7%
|
5,781,066
|
$232,051,989 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.4%
|
5,604,876
|
$224,979,722 | — | 30 Sep 2025 | |
| Bellevue Group AG |
13F
|
Company |
6.3%
|
3,714,736
|
$149,109,503 | — | 30 Sep 2025 | |
| Erste Asset Management GmbH |
13F
|
Company |
4.7%
|
2,764,900
|
$108,577,623 | — | 30 Sep 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
4.2%
|
2,471,416
|
$99,202,637 | — | 30 Sep 2025 | |
| Commodore Capital LP |
13F
|
Company |
3.9%
|
2,338,287
|
$93,858,840 | — | 30 Sep 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
3.3%
|
1,958,101
|
$78,598,000 | — | 30 Sep 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.8%
|
1,656,938
|
$66,510,000 | — | 30 Sep 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
2.4%
|
1,430,041
|
$57,401,846 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
1,416,315
|
$56,859,764 | — | 30 Sep 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
2.2%
|
1,279,754
|
$51,369,326 | — | 30 Sep 2025 | |
| Caligan Partners LP |
13F
|
Company |
1.9%
|
1,131,205
|
$45,406,569 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.9%
|
1,130,000
|
$45,358,199 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.7%
|
1,021,201
|
$40,987,144 | — | 30 Sep 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
1.7%
|
987,339
|
$39,631,000 | — | 30 Sep 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.6%
|
958,542
|
$38,475,876 | — | 30 Sep 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.6%
|
926,734
|
$37,199,103 | — | 30 Sep 2025 | |
| Fisher Asset Management, LLC |
13F
|
Company |
1.5%
|
870,145
|
$34,927,619 | — | 30 Sep 2025 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.4%
|
852,942
|
$34,238,000 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.4%
|
804,766
|
$32,303,307 | — | 30 Sep 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.3%
|
800,000
|
$32,112,000 | — | 30 Sep 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
1.3%
|
764,000
|
$30,666,960 | — | 30 Sep 2025 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.1%
|
679,922
|
$27,292,069 | — | 30 Sep 2025 | |
| SCS Capital Management LLC |
13F
|
Company |
1%
|
598,765
|
$24,034,427 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.93%
|
555,410
|
$22,294,158 | — | 30 Sep 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.89%
|
530,098
|
$21,278,134 | — | 30 Sep 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.83%
|
495,491
|
$19,889,009 | — | 30 Sep 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.83%
|
495,341
|
$19,882,988 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.83%
|
491,982
|
$19,748,157 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.81%
|
482,186
|
$19,354,946 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.7%
|
416,998
|
$16,738,360 | — | 30 Sep 2025 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.68%
|
402,943
|
$16,174,132 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.66%
|
395,120
|
$15,860,117 | — | 30 Sep 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.62%
|
367,749
|
$14,761,445 | — | 30 Sep 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.54%
|
322,934
|
$12,962,569 | — | 30 Sep 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.46%
|
272,161
|
$10,694,859 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.45%
|
270,096
|
$10,841,639 | — | 30 Sep 2025 | |
| Palo Alto Investors LP |
13F
|
Company |
0.45%
|
265,497
|
$10,657,050 | — | 30 Sep 2025 | |
| SummitTX Capital, L.P. |
13F
|
Company |
0.44%
|
262,977
|
$10,555,897 | — | 30 Sep 2025 | |
| Eagle Health Investments LP |
13F
|
Company |
0.41%
|
246,230
|
$9,883,672 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.41%
|
242,813
|
$9,746,514 | — | 30 Sep 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.38%
|
226,824
|
$9,104,715 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.36%
|
216,040
|
$8,671,845 | — | 30 Sep 2025 | |
| HighVista Strategies LLC |
13F
|
Company |
0.33%
|
195,298
|
$7,839,262 | — | 30 Sep 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.32%
|
189,866
|
$7,621,221 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.31%
|
183,100
|
$7,349,634 | — | 30 Sep 2025 |
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO) as of Q4 2025
As of 31 Dec 2025,
AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO) was held by
237 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,265,073 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., FARALLON CAPITAL MANAGEMENT LLC, STATE STREET CORP, ARMISTICE CAPITAL, LLC, Erste Asset Management GmbH, D. E. Shaw & Co., Inc., NOMURA ASSET MANAGEMENT INTERNATIONAL INC., GEODE CAPITAL MANAGEMENT, LLC, and BNP PARIBAS ASSET MANAGEMENT Holding S.A..
This page lists
237
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
216
Q4 2025 holders
237
Holder diff
21
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.